The bill (Reg. No. 4623) was elaborated in view of determining
additional sources for financing measures on prevention and treatment of rare
(orphan) diseases; reimbursement of costs of outpatient medicine consumption; as well as activity
connected with bone marrow transplantation.
Return to posts
The document suggests channeling 60 per cent of VAT taxation revenues from transactions on medical products and drugs supply to the State Budget for financing prevention and treatment of rare (orphan) diseases; reimbursement of costs of outpatient medicine consumption; and activity connected with bone marrow transplantation.
More posts by topic
“News 2”
24 March 2023 11:30
15 December 2020 19:15
15 December 2020 12:36
15 December 2020 12:00
12 December 2020 15:18
07 December 2020 15:21
07 December 2020 11:30
05 December 2020 10:15
05 November 2020 13:05
05 November 2020 13:05